Bupa launches AI assisted skin cancer assessment service

Bupa has become the first UK insurer to integrate AI into its at-home skin assessment service for moles and lesions. The service uses Skin Analytics’ DERM system, which the company said is the only Class III CE-marked artificial intelligence medical device approved for autonomous use in skin cancer care. The technology can assess images of…